JONES EDWARD RAYMOND purchased 9.2% of their position (7.52K shares) of CYTOSORBENTS CORP on the open market
Open‑market purchase worth $10.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/15/2023ACC: 0001104659-23-126428
+10.15K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
10.15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.52K
Price / share
$1.33
Trade value
$10K
% of position
9.2%
12/13/2023
81.31K→88.83K
Total
Net shares
+7.52K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/13/2023 | P · Purchase | +7.52K | $1.33 | $10K | 9.2% | 81.31K | 88.83K |
| Total | +7.52K | $10K | ||||||
Derivative Transactions1
Common Stock Warrant (Right to Buy)
Direct
Converts to
Common Stock
2.63K shares
Shares
+2.63K
Strike price
2.00
Held after
2.63K
Exercisable
—
12/13/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Warrant (Right to Buy) Direct | Common Stock2.63K shares | 12/13/2023 | P · Purchase | +2.63K | 2.00 | — | 2.63K |